Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:


Subscribers log in here


Aspiration pneumonia in adults

INTRODUCTION

Aspiration is a common event even in healthy individuals and usually resolves without detectable sequelae. Markers placed in the stomach can often be detected in the lungs of healthy persons using scintigraphic methods [1]. Sensitive tests show that at least one-half of healthy adults aspirate during sleep [2]. Pulmonary sequelae depend upon the volume and contents of the inoculum and host defense mechanisms. Aspiration pneumonia refers to the pulmonary consequences resulting from this abnormal entry of fluid, particulate exogenous substances, or endogenous secretions into the lower airways. There are usually two requirements to produce aspiration pneumonia:

Compromise in the usual defenses that protect the lower airways including glottic closure, cough reflex, and other clearing mechanisms

An inoculum deleterious to the lower airways by a direct toxic effect (such as gastric acid), stimulation of an inflammatory process from bacterial infection, or obstruction due to uncleared fluid or particulate matter

Most pneumonia arises following the aspiration of microorganisms from the oral cavity or nasopharynx. The term aspiration pneumonia should be reserved for pneumonitis resulting from the altered clearance defenses noted above. The pathogens that commonly produce pneumonia, such as Streptococcus pneumoniae, Haemophilus influenzae, gram-negative bacilli, and Staphylococcus aureus, are relatively virulent bacteria so that only a small inoculum is required and the aspiration is usually subtle. A true aspiration pneumonia, by convention, usually refers to an infection caused by less virulent bacteria, primarily anaerobes, which are common constituents of the normal flora in a susceptible host prone to aspiration. In a review of 1348 patients hospitalized with community-acquired pneumonia, 13.8 percent were considered to be at risk for aspiration; risk factors included neurologic disorders, reduced consciousness, esophageal disorders, vomiting, or witnessed aspiration [3].

The predisposing conditions, clinical syndromes, diagnosis, and treatment of aspiration pneumonia will be reviewed here. Community-acquired pneumonia, hospital-acquired pneumonia, pneumonia due to specific pathogens, empyema, and lung abscess are discussed separately. (See related topic reviews.)

                     

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Jun 2014. | This topic last updated: Dec 12, 2013.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Berson W, Adriani J. Silent regurgitation and aspiration during anesthesia. Anesthesiology 1954; 15:644.
  2. Huxley EJ, Viroslav J, Gray WR, Pierce AK. Pharyngeal aspiration in normal adults and patients with depressed consciousness. Am J Med 1978; 64:564.
  3. Taylor JK, Fleming GB, Singanayagam A, et al. Risk factors for aspiration in community-acquired pneumonia: analysis of a hospitalized UK cohort. Am J Med 2013; 126:995.
  4. Reza Shariatzadeh M, Huang JQ, Marrie TJ. Differences in the features of aspiration pneumonia according to site of acquisition: community or continuing care facility. J Am Geriatr Soc 2006; 54:296.
  5. Cabre M, Serra-Prat M, Palomera E, et al. Prevalence and prognostic implications of dysphagia in elderly patients with pneumonia. Age Ageing 2010; 39:39.
  6. Smith Hammond C. Cough and aspiration of food and liquids due to oral pharyngeal Dysphagia. Lung 2008; 186 Suppl 1:S35.
  7. Smith HA, Lee SH, O'Neill PA, Connolly MJ. The combination of bedside swallowing assessment and oxygen saturation monitoring of swallowing in acute stroke: a safe and humane screening tool. Age Ageing 2000; 29:495.
  8. Fink TA, Ross JB. Are we testing a true thin liquid? Dysphagia 2009; 24:285.
  9. Osawa A, Maeshima S, Tanahashi N. Water-swallowing test: screening for aspiration in stroke patients. Cerebrovasc Dis 2013; 35:276.
  10. Fox KA, Mularski RA, Sarfati MR, et al. Aspiration pneumonia following surgically placed feeding tubes. Am J Surg 1995; 170:564.
  11. Spain DA, DeWeese RC, Reynolds MA, Richardson JD. Transpyloric passage of feeding tubes in patients with head injuries does not decrease complications. J Trauma 1995; 39:1100.
  12. Marik PE. Aspiration pneumonitis and aspiration pneumonia. N Engl J Med 2001; 344:665.
  13. Orozco-Levi M, Torres A, Ferrer M, et al. Semirecumbent position protects from pulmonary aspiration but not completely from gastroesophageal reflux in mechanically ventilated patients. Am J Respir Crit Care Med 1995; 152:1387.
  14. Loeb MB, Becker M, Eady A, Walker-Dilks C. Interventions to prevent aspiration pneumonia in older adults: a systematic review. J Am Geriatr Soc 2003; 51:1018.
  15. Logemann JA, Gensler G, Robbins J, et al. A randomized study of three interventions for aspiration of thin liquids in patients with dementia or Parkinson's disease. J Speech Lang Hear Res 2008; 51:173.
  16. Robbins J, Gensler G, Hind J, et al. Comparison of 2 interventions for liquid aspiration on pneumonia incidence: a randomized trial. Ann Intern Med 2008; 148:509.
  17. Bartlett JG, Gorbach SL. The triple threat of aspiration pneumonia. Chest 1975; 68:560.
  18. MENDELSON CL. The aspiration of stomach contents into the lungs during obstetric anesthesia. Am J Obstet Gynecol 1946; 52:191.
  19. Bynum LJ, Pierce AK. Pulmonary aspiration of gastric contents. Am Rev Respir Dis 1976; 114:1129.
  20. Doyle RL, Szaflarski N, Modin GW, et al. Identification of patients with acute lung injury. Predictors of mortality. Am J Respir Crit Care Med 1995; 152:1818.
  21. Wu YC, Hsu PK, Su KC, et al. Bile acid aspiration in suspected ventilator-associated pneumonia. Chest 2009; 136:118.
  22. Teabeaut Jr 2nd. Aspiration of gastric contents; an experimental study. Am J Pathol 1952; 28:51.
  23. Fisk RL, Symes JF, Aldridge LL, Couves CM. The pathophysiology and experimental therapy of acid pneumonitis in ex vivo lungs. Chest 1970; 57:364.
  24. Cameron JL, Caldini P, Toung JK, Zuidema GD. Aspiration pneumonia: physiologic data following experimental aspiration. Surgery 1972; 72:238.
  25. Mays EE, Dubois JJ, Hamilton GB. Pulmonary fibrosis associated with tracheobronchial aspiration. A study of the frequency of hiatal hernia and gastroesophageal reflux in interstitial pulmonary fibrosis of obscure etiology. Chest 1976; 69:512.
  26. Johnson LF, Rajagopal KR. Aspiration resulting from gastroesophageal reflux. A cause of chronic bronchopulmonary disease. Chest 1988; 93:676.
  27. Folkesson HG, Matthay MA, Hébert CA, Broaddus VC. Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms. J Clin Invest 1995; 96:107.
  28. Yamada H, Kudoh I, Nishizawa H, et al. Complement partially mediates acid aspiration-induced remote organ injury in the rat. Acta Anaesthesiol Scand 1997; 41:713.
  29. Goldman G, Welbourn R, Kobzik L, et al. Tumor necrosis factor-alpha mediates acid aspiration-induced systemic organ injury. Ann Surg 1990; 212:513.
  30. Sladen A, Zanca P, Hadnott WH. Aspiration pneumonitis--the sequelae. Chest 1971; 59:448.
  31. Steiner J, Bachofen M, Bachofen H. Recovery from aspiration pneumonitis. Pneumonologie 1974; 151:127.
  32. DePaso WJ. Aspiration pneumonia. Clin Chest Med 1991; 12:269.
  33. Broe PJ, Toung TJ, Permutt S, Cameron JL. Aspiration pneumonia: treatment with pulmonary vasodilators. Surgery 1983; 94:95.
  34. Cameron JL, Sebor J, Anderson RP, Zuidema GD. Aspiration pneumonia. Results of treatment by positive-pressure ventilation in dogs. J Surg Res 1968; 8:447.
  35. Peitzman, AB, Shires, GT 3d, Illner, HK, Shires, GT. Pulmonary acid injury: Effects of positive end-expiratory pressure and crystalloid vs colloid fluid resuscitation. Arch Surg 1982; 117:662.
  36. Toung TJ, Cameron JL, Kimura T, Permutt S. Aspiration pneumonia: treatment with osmotically active agents. Surgery 1981; 89:588.
  37. Broe PJ, Toung TJ, Cameron JL. Aspiration pneumonia. Surg Clin North Am 1980; 60:1551.
  38. Toung TJ, Bordos D, Benson DW, et al. Aspiration pneumonia: experimental evaluation of albumin and steroid therapy. Ann Surg 1976; 183:179.
  39. Chapman RL Jr, Downs JB, Modell JH, Hood CI. The ineffectiveness of steroid therapy in treating aspiration of hydrochloric acid. Arch Surg 1974; 108:858.
  40. Wolfe JE, Bone RC, Ruth WE. Effects of corticosteroids in the treatment of patients with gastric aspiration. Am J Med 1977; 63:719.
  41. Johanson WG Jr, Stephen JJ, Pierce AK. Bacterial growth in vivo. An important determinant of the pulmonary clearance of Diplococcus pneumoniae in rats. J Clin Invest 1974; 53:1320.
  42. Cameron JL, Mitchell WH, Zuidema GD. Aspiration pneumonia. Clinical outcome following documented aspiration. Arch Surg 1973; 106:49.
  43. Dines DE, Titus JL, Sessler AD. Aspiration pneumonitis. Mayo Clin Proc 1970; 45:347.
  44. Bartlett JG. How important are anaerobic bacteria in aspiration pneumonia: when should they be treated and what is optimal therapy. Infect Dis Clin North Am 2013; 27:149.
  45. El-Solh AA, Pietrantoni C, Bhat A, et al. Microbiology of severe aspiration pneumonia in institutionalized elderly. Am J Respir Crit Care Med 2003; 167:1650.
  46. Mier L, Dreyfuss D, Darchy B, et al. Is penicillin G an adequate initial treatment for aspiration pneumonia? A prospective evaluation using a protected specimen brush and quantitative cultures. Intensive Care Med 1993; 19:279.
  47. Polverino E, Dambrava P, Cillóniz C, et al. Nursing home-acquired pneumonia: a 10 year single-centre experience. Thorax 2010; 65:354.
  48. Carratalà J, Mykietiuk A, Fernández-Sabé N, et al. Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med 2007; 167:1393.
  49. Bartlett JG, O'Keefe P, Tally FP, et al. Bacteriology of hospital-acquired pneumonia. Arch Intern Med 1986; 146:868.
  50. Bartlett JG. Anaerobic bacterial infections of the lung and pleural space. Clin Infect Dis 1993; 16 Suppl 4:S248.
  51. Finegold SM. Aspiration pneumonia. Rev Infect Dis 1991; 13 Suppl 9:S737.
  52. Bartlett JG. Anaerobic bacterial pneumonitis. Am Rev Respir Dis 1979; 119:19.
  53. Lorber B, Swenson RM. Bacteriology of aspiration pneumonia. A prospective study of community- and hospital-acquired cases. Ann Intern Med 1974; 81:329.
  54. Beerens H, Tahon-Castel M. Infection Humaines a Bacteries Anaerobies Non-toxigenes, Presses Academiques Europeennes, Brussels 1965. p.91.
  55. Finegold SM, George WL, Mulligan ME. Anaerobic infections. Part II. Dis Mon 1985; 31:1.
  56. Yamashita Y, Kohno S, Tanaka K, et al. [Anaerobic respiratory infection--evaluation of methods of obtaining specimens]. Kansenshogaku Zasshi 1994; 68:631.
  57. Bartlett JG. Diagnostic accuracy of transtracheal aspiration bacteriologic studies. Am Rev Respir Dis 1977; 115:777.
  58. Wimberley NW, Bass JB Jr, Boyd BW, et al. Use of a bronchoscopic protected catheter brush for the diagnosis of pulmonary infections. Chest 1982; 81:556.
  59. Henriquez AH, Mendoza J, Gonzalez PC. Quantitative culture of bronchoalveolar lavage from patients with anaerobic lung abscesses. J Infect Dis 1991; 164:414.
  60. Brook I, Finegold SM. Bacteriology of aspiration pneumonia in children. Pediatrics 1980; 65:1115.
  61. Takayanagi N, Kagiyama N, Ishiguro T, et al. Etiology and outcome of community-acquired lung abscess. Respiration 2010; 80:98.
  62. Bartlett JG. Anaerobic bacterial infection of the lung. Anaerobe 2012; 18:235.
  63. Johanson WG, Pierce AK, Sanford JP. Changing pharyngeal bacterial flora of hospitalized patients. Emergence of gram-negative bacilli. N Engl J Med 1969; 281:1137.
  64. Bartlett JG. Treatment of anaerobic pleuropulmonary infections. Ann Intern Med 1975; 83:376.
  65. Weiss W. Oral antibiotic therapy of acute primary lung abscess: comparison of penicillin G and tetracycline. Curr Ther Res Clin Exp 1970; 12:154.
  66. Weiss W. Cavity behavior in acute, primary, nonspecific lung abscess. Am Rev Respir Dis 1973; 108:1273.
  67. Levison ME, Mangura CT, Lorber B, et al. Clindamycin compared with penicillin for the treatment of anaerobic lung abscess. Ann Intern Med 1983; 98:466.
  68. Gudiol F, Manresa F, Pallares R, et al. Clindamycin vs penicillin for anaerobic lung infections. High rate of penicillin failures associated with penicillin-resistant Bacteroides melaninogenicus. Arch Intern Med 1990; 150:2525.
  69. Kadowaki M, Demura Y, Mizuno S, et al. Reappraisal of clindamycin IV monotherapy for treatment of mild-to-moderate aspiration pneumonia in elderly patients. Chest 2005; 127:1276.
  70. Germaud P, Poirier J, Jacqueme P, et al. [Monotherapy using amoxicillin/clavulanic acid as treatment of first choice in community-acquired lung abscess. Apropos of 57 cases]. Rev Pneumol Clin 1993; 49:137.
  71. Eykyn SJ. The therapeutic use of metronidazole in anaerobic infection: six years' experience in a London hospital. Surgery 1983; 93:209.
  72. Sanders CV, Hanna BJ, Lewis AC. Metronidazole in the treatment of anaerobic infections. Am Rev Respir Dis 1979; 120:337.
  73. Perlino CA. Metronidazole vs clindamycin treatment of anerobic pulmonary infection. Failure of metronidazole therapy. Arch Intern Med 1981; 141:1424.
  74. Ott SR, Allewelt M, Lorenz J, et al. Moxifloxacin vs ampicillin/sulbactam in aspiration pneumonia and primary lung abscess. Infection 2008; 36:23.
  75. Snydman DR, Jacobus NV, McDermott LA, et al. Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007). Clin Infect Dis 2010; 50 Suppl 1:S26.
  76. Colebatch, HJ, Halmagyi, DF. Reflex airway reaction to fluid aspiration. J Appl Physiol 1964; 17:787.
  77. Gipson SL, Stovall TG, Elkins TE, Crumrine RS. Pharmacologic reduction of the risk of aspiration. South Med J 1986; 79:1356.
  78. Abdulmajid OA, Ebeid AM, Motaweh MM, Kleibo IS. Aspirated foreign bodies in the tracheobronchial tree: report of 250 cases. Thorax 1976; 31:635.
  79. Brooks JW. Foreign bodies in the air and food passages. Ann Surg 1972; 175:720.
  80. Kim IG, Brummitt WM, Humphry A, et al. Foreign body in the airway: a review of 202 cases. Laryngoscope 1973; 83:347.
  81. Baharloo F, Veyckemans F, Francis C, et al. Tracheobronchial foreign bodies: presentation and management in children and adults. Chest 1999; 115:1357.
  82. Haugen RK. The cafe coronary. Sudden deaths in restaurants. JAMA 1963; 186:142.
  83. Lansing AM, Jamieson WG. Mechanisms of fever in pulmonary atelectasis. Arch Surg 1963; 87:184.
  84. Hedblom CA. Foreign bodies of dental origin in a bronchus pulmonary complication. Ann Surg 1920; 71:568.
  85. Zavala DC, Rhodes ML. Foreign body removal: a new role for the fiberoptic bronchoscope. Ann Otol Rhinol Laryngol 1975; 84:650.
  86. Spickard A 3rd, Hirschmann JV. Exogenous lipoid pneumonia. Arch Intern Med 1994; 154:686.
  87. Betancourt SL, Martinez-Jimenez S, Rossi SE, et al. Lipoid pneumonia: spectrum of clinical and radiologic manifestations. AJR Am J Roentgenol 2010; 194:103.
  88. Marchiori E, Zanetti G, Mano CM, et al. Lipoid pneumonia in 53 patients after aspiration of mineral oil: comparison of high-resolution computed tomography findings in adults and children. J Comput Assist Tomogr 2010; 34:9.